Cargando…

Pharmacogenetic Perturbations in Humans as a Tool to Generate Mechanistic Insight

Detalles Bibliográficos
Autor principal:	Florez, Jose C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2013
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3749360/ https://www.ncbi.nlm.nih.gov/pubmed/23970522 http://dx.doi.org/10.2337/db13-0871

Ejemplares similares

Mechanistic insights into influenza vaccine-associated narcolepsy
por: Ahmed, S. Sohail, et al.
Publicado: (2016)

Proteogenomics unveils mechanistic insights to precision oncology
por: Dou, Yongchao, et al.
Publicado: (2023)

Genomic discoveries unveil mechanistic insights in diabetes
por: Florez, Jose C.
Publicado: (2022)

Evidence Regarding Pharmacogenetics in Pain Management and Cancer
por: Smith, D Max, et al.
Publicado: (2023)

Mechanistic insights into the role of mTOR signaling in neuronal differentiation
por: Bateman, Joseph M
Publicado: (2015)

Zinc–rs13266634 and the Arrival of Diabetes Pharmacogenetics: The “Zinc Mystique”
por: Maruthur, Nisa M., et al.
Publicado: (2014)

Editorial: Insights in Pharmacogenetics and Pharmacogenomics: 2021
por: Agúndez, José A. G., et al.
Publicado: (2022)

Conventional, Complementary and Alternative Medicines: Mechanistic Insights into Therapeutic Landscape of Chronic Obstructive Pulmonary Disease
por: Arezina, Radivoj, et al.
Publicado: (2023)

Mechanistic understanding of the role of ATRX in senescence provides new insight for combinatorial therapies with CDK4 inhibitors.
por: Kovatcheva, Marta, et al.
Publicado: (2017)

Prolonged Inflammatory Response Post-Hypoglycemia: Mechanistic Insights Into the Relationship Between Low Glucose and Cardiovascular Risk
por: Iqbal, Ahmed, et al.
Publicado: (2022)

Could pharmacogenetic data explain part of the interindividual sensitivity to methadone-induced respiratory depression?
por: Crettol, Séverine, et al.
Publicado: (2007)

Potential Use of Pharmacogenetics to Reduce Drug-Induced Syndrome of Inappropriate Antidiuretic Hormone (SIADH)
por: Wilke, Russell A.
Publicado: (2021)

Pharmacogenetics in type 2 diabetes: potential implications for clinical practice
por: Huang, Chunmei, et al.
Publicado: (2011)

Quantification of biological network perturbations for mechanistic insight and diagnostics using two-layer causal models
por: Martin, Florian, et al.
Publicado: (2014)

Pharmacogenetic screening in a knowledge-based economy: shouldn’t more be better?
por: Alter, David A.
Publicado: (2022)

Insights from pharmacogenetic studies of antidepressants
por: Mandelli, Laura
Publicado: (2010)

Insights into the Pharmacogenetics of Tacrolimus Pharmacokinetics and Pharmacodynamics
por: Brunet, Mercè, et al.
Publicado: (2022)

Current perspectives on interethnic variability in multiple myeloma: Single cell technology, population pharmacogenetics and molecular signal transduction
por: Gandhi, Manav, et al.
Publicado: (2022)

Generative AI as a Tool for Environmental Health Research Translation
por: Anderson, Lauren B., et al.
Publicado: (2023)

Commentary on Ivancic et al.: Enzyme kinetics from circular dichroism of insulin reveals mechanistic insights into the regulation of insulin-degrading enzyme
por: Grasso, Giuseppe
Publicado: (2018)

Mechanistic complexity of contractile dysfunction in hypertrophic cardiomyopathy
por: Regnier, Michael
Publicado: (2018)

Anticancer Drug-Induced Cardiotoxicity: Insights and Pharmacogenetics
por: Adhikari, Archana, et al.
Publicado: (2021)

Commentary: mechanistic considerations for associations between formaldehyde exposure and nasopharyngeal carcinoma
por: Thompson, Chad M, et al.
Publicado: (2009)

Mechanistic Vs. Empirical Network Models of Drug Action
por: Birtwistle, M R, et al.
Publicado: (2013)

Movies, measurement, and modeling: the three Ms of mechanistic immunology
por: Witt, Colleen, et al.
Publicado: (2005)

Mechanistic Models of Infectious Disease and Their Impact on Public Health
por: Lessler, Justin, et al.
Publicado: (2016)

Integrating functional genomics to accelerate mechanistic personalized medicine
por: Tyner, Jeffrey W.
Publicado: (2017)

Perturbations in Traffic: Aberrant Nucleocytoplasmic Transport at the Heart of Neurodegeneration
por: Fahrenkrog, Birthe, et al.
Publicado: (2018)

Collaborative cloud-enabled tools allow rapid, reproducible biological insights
por: Ragan-Kelley, Benjamin, et al.
Publicado: (2013)

“Black box” pharmacogenetic decision-support tools in psychiatry
por: Bousman, Chad A., et al.
Publicado: (2020)

The Perturbance of Microbiome and Gut-Brain Axis in Autism Spectrum Disorders
por: Fowlie, Greta, et al.
Publicado: (2018)

Proposed Key Characteristics of Male Reproductive Toxicants as an Approach for Organizing and Evaluating Mechanistic Evidence in Human Health Hazard Assessments
por: Arzuaga, Xabier, et al.
Publicado: (2019)

A Genome-Wide Association Study of Treated A1C: A Genetic Needle in an Environmental Haystack?
por: Florez, Jose C.
Publicado: (2010)

Efficacy and effectiveness trials have different goals, use different tools, and generate different messages
por: Porzsolt, Franz, et al.
Publicado: (2015)

Pharmacogenetic Testing: A Tool for Personalized Drug Therapy Optimization
por: Malsagova, Kristina A., et al.
Publicado: (2020)

Comparing Ease of Programming in C++, Go, and Java for Implementing a Next-Generation Sequencing Tool
por: Costanza, Pascal, et al.
Publicado: (2019)

Exercise and the Microbiome: Mechanistic Perspectives of the Impact of Exercise on the Gut-Vascular Axis
por: Cook, Marc D., et al.
Publicado: (2021)

Epigenetics, ovarian cell plasticity, and platelet-rich plasma: Mechanistic theories
por: Sills, E Scott, et al.
Publicado: (2022)

Landscape and perturbation of enhancer-driven core transcription regulatory circuits in cancer
por: Xu, Juan, et al.
Publicado: (2023)

Pharmacogenetics of lipid diseases
por: Ordovas, Jose M
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_5pvarkfvj6a1nap5b3qjcqjf07